Rentokil Initial plc (OTCMKTS:RTOKY) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $35.39 and traded as high as $36.50. Rentokil Initial shares last traded at $34.87, with a volume of 50,439 shares traded.

Several research firms have recently commented on RTOKY. Zacks Investment Research downgraded shares of Rentokil Initial from a “hold” rating to a “sell” rating in a report on Thursday, December 24th. Berenberg Bank assumed coverage on shares of Rentokil Initial in a report on Tuesday, February 2nd. They issued a “sell” rating on the stock. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Rentokil Initial in a research note on Thursday, January 14th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Rentokil Initial in a report on Tuesday, January 12th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company’s stock. Rentokil Initial currently has a consensus rating of “Hold” and a consensus price target of $39.00.

The company has a quick ratio of 0.96, a current ratio of 1.05 and a debt-to-equity ratio of 1.06. The company’s 50-day moving average is $36.41 and its 200 day moving average is $35.39. The company has a market cap of $12.93 billion, a price-to-earnings ratio of 37.90 and a beta of 0.84.

Rentokil Initial Company Profile (OTCMKTS:RTOKY)

Rentokil Initial plc, through its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services from rodents to flying and crawling insects, as well as to other forms of wildlife management for commercial and residential customers.

Featured Article: Bollinger Bands

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.